11/08/2024
7:18 AM | Myriad Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/11/2024
4:23 PM | DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
9:35 AM | DIAZ PAUL J (Reporting)
Myriad Genetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
3:31 PM | Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
3:33 PM | Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
3:36 PM | Myriad Genetics (Issuer)
Verratti Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
5:11 AM | Myriad Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
09/23/2024
3:15 PM | Munk Natalie (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:17 PM | Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:21 PM | Myriad Genetics (Issuer)
Verratti Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
1:30 PM | Ancona Margaret (Reporting)
Myriad Genetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:09 PM | Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:11 PM | DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
2:26 PM | Muzzey Dale (Reporting)
Myriad Genetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
9:05 AM | DIAZ PAUL J (Reporting)
Myriad Genetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
4:48 PM | Dreismann Heinrich (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
1:52 PM | Dreismann Heinrich (Reporting)
Myriad Genetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
6:51 PM | Fox Jennifer Lynne (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
6:38 PM | Myriad Genetics (Issuer)
Reitan Colleen F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
7:43 PM | Myriad Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
3:33 PM | Fox Jennifer Lynne (Reporting)
Myriad Genetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
9:11 AM | Myriad Genetics (Subject)
Reitan Colleen F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:48 PM | Munk Natalie (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:16 PM | Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:38 PM | Kumar Rashmi (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
1:46 PM | Kumar Rashmi (Reporting)
Myriad Genetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
3:27 PM | DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
7:22 AM | Myriad Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/04/2024
4:57 PM | Myriad Genetics (Issuer)
SPIEGELMAN DANIEL K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
9:32 AM | Myriad Genetics (Subject)
SPIEGELMAN DANIEL K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
12:48 PM | Myriad Genetics (Subject)
SPIEGELMAN DANIEL K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
4:48 PM | Myriad Genetics (Issuer)
Newcomer Lee Nisley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
4:49 PM | DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
3:24 PM | DIAZ PAUL J (Reporting)
Myriad Genetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
11:14 AM | Myriad Genetics (Subject)
Newcomer Lee Nisley (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024
7:14 AM | Myriad Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/17/2024
3:31 PM | Myriad Genetics (Filer)
| Form DEF 14A | |
04/17/2024
3:31 PM | Myriad Genetics (Filer)
| Form DEFA14A | |
04/17/2024
3:33 PM | Myriad Genetics (Filer)
| Form ARS | |
04/15/2024
3:25 PM | Myriad Genetics (Issuer)
Verratti Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:27 PM | Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
2025: Digital Asset Insights You Need to Know (Ad) Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto.
Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential. Get your guide today! |
04/08/2024
3:49 PM | Munk Natalie (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
3:39 PM | MILLENNIUM MANAGEMENT LLC (Filed by)
Myriad Genetics (Subject)
| Form SC 13G | |
03/04/2024
3:18 PM | Myriad Genetics (Issuer)
Solaiman Shereen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
7:31 AM | Myriad Genetics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
7:24 AM | Camber Capital Management LP (Filed by)
Myriad Genetics (Subject)
| Form SC 13G/A | |
01/29/2024
3:21 PM | Leffler Scott J. (Reporting)
Myriad Genetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/29/2024
3:27 PM | Leffler Scott J. (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
12:20 PM | Myriad Genetics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/23/2024
3:31 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Myriad Genetics (Subject)
| Form SC 13G/A | |
01/22/2024
1:03 PM | BlackRock Inc. (Filed by)
Myriad Genetics (Subject)
| Form SC 13G/A | |
01/16/2024
8:00 AM | Myriad Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
4:52 PM | Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
7:30 AM | Myriad Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
5:34 PM | Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/11/2023
5:41 PM | Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:19 PM | Myriad Genetics (Issuer)
Riggsbee Richard Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
